The Fuchs corneal dystrophy-associated CTG repeat expansion in the TCF4 gene affects transcription from its alternative promoters.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 10 2020
Historique:
received: 17 08 2020
accepted: 14 10 2020
entrez: 29 10 2020
pubmed: 30 10 2020
medline: 11 3 2021
Statut: epublish

Résumé

The CTG trinucleotide repeat (TNR) expansion in Transcription factor 4 (TCF4) intron 3 is the main cause of Fuchs' endothelial corneal dystrophy (FECD) and may confer an increased risk of developing bipolar disorder (BD). Usage of alternative 5' exons for transcribing the human TCF4 gene results in numerous TCF4 transcripts which encode for at least 18 N-terminally different protein isoforms that vary in their function and transactivation capability. Here we studied the TCF4 region containing the CTG TNR and characterized the transcription initiation sites of the nearby downstream 5' exons 4a, 4b and 4c. We demonstrate that these exons are linked to alternative promoters and show that the CTG TNR expansion decreases the activity of the nearby downstream TCF4 promoters in primary cultured neurons. We confirm this finding using two RNA sequencing (RNA-seq) datasets of corneal endothelium from FECD patients with expanded CTG TNR in the TCF4 gene. Furthermore, we report an increase in the expression of various other TCF4 transcripts in FECD, possibly indicating a compensatory mechanism. We conclude that the CTG TNR affects TCF4 expression in a transcript-specific manner both in neurons and in the cornea.

Identifiants

pubmed: 33116252
doi: 10.1038/s41598-020-75437-3
pii: 10.1038/s41598-020-75437-3
pmc: PMC7595208
doi:

Substances chimiques

TCF4 protein, human 0
Transcription Factor 4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18424

Subventions

Organisme : Marie Curie
ID : EU734791
Pays : United Kingdom

Références

Mol Cell Proteomics. 2014 Feb;13(2):397-406
pubmed: 24309898
J Neurosci. 2017 Oct 25;37(43):10516-10527
pubmed: 28951451
Curr Opin Cell Biol. 2008 Jun;20(3):253-9
pubmed: 18436437
Mol Psychiatry. 2016 Aug;21(8):1112-24
pubmed: 26481318
Nat Rev Dis Primers. 2018 Mar 08;4:18008
pubmed: 29516993
Invest Ophthalmol Vis Sci. 2015 Feb 26;56(3):2003-11
pubmed: 25722209
Development. 2007 Nov;134(21):3771-80
pubmed: 17898002
Acta Neuropathol Commun. 2017 Aug 29;5(1):63
pubmed: 28851463
Neurobiol Dis. 2020 Mar;136:104740
pubmed: 31927143
Invest Ophthalmol Vis Sci. 2019 Sep 3;60(12):3980-3991
pubmed: 31560764
Eur J Hum Genet. 2002 Apr;10(4):276-80
pubmed: 12032737
Handb Clin Neurol. 2018;147:105-123
pubmed: 29325606
Nature. 2009 Aug 6;460(7256):744-7
pubmed: 19571808
Prog Retin Eye Res. 2020 May 8;:100863
pubmed: 32438095
In Silico Biol. 2004;4(4):429-44
pubmed: 15506993
Nat Biotechnol. 2004 Jun;22(6):707-16
pubmed: 15146197
Am J Hum Genet. 2018 Apr 5;102(4):528-539
pubmed: 29526280
Invest Ophthalmol Vis Sci. 2019 Feb 1;60(2):779-786
pubmed: 30811544
Prog Retin Eye Res. 2020 Jul 28;:100883
pubmed: 32735996
Genome Biol. 2015 Jan 05;16:22
pubmed: 25723102
Nat Genet. 2018 May;50(5):668-681
pubmed: 29700475
Am J Hum Genet. 2007 May;80(5):994-1001
pubmed: 17436255
Neuron. 2013 Mar 6;77(5):825-43
pubmed: 23473314
J Biol Chem. 2015 Mar 6;290(10):5979-90
pubmed: 25593321
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Sci Adv. 2019 Sep 11;5(9):eaau4139
pubmed: 31535015
Mol Cell Biol. 1996 Jun;16(6):2898-905
pubmed: 8649400
Hum Mol Genet. 2018 Mar 15;27(6):1015-1026
pubmed: 29325021
Nature. 2017 Oct 11;550(7675):190-191
pubmed: 29022577
Ann Neurol. 2014 Oct;76(4):522-8
pubmed: 25112975
PLoS One. 2012;7(11):e49083
pubmed: 23185296
Eur J Med Genet. 2016 Jun;59(6-7):310-4
pubmed: 27132474
Nucleic Acids Res. 2020 Jul 9;48(12):6740-6758
pubmed: 32463444
Biomed Res Int. 2015;2015:640234
pubmed: 26451375
Graefes Arch Clin Exp Ophthalmol. 2017 Aug;255(8):1621-1631
pubmed: 28608272
Data Brief. 2019 May 23;25:104047
pubmed: 31205988
JAMA Ophthalmol. 2015 Dec;133(12):1386-91
pubmed: 26401622
PLoS Genet. 2014 Apr 24;10(4):e1004242
pubmed: 24763282
Curr Genet Med Rep. 2017 Mar;5(1):1-7
pubmed: 30775158
J Neurosci. 2020 Feb 12;40(7):1405-1426
pubmed: 31915257
Transl Psychiatry. 2018 Mar 15;8(1):67
pubmed: 29540662
PLoS One. 2011;6(7):e22138
pubmed: 21789225

Auteurs

Alex Sirp (A)

Department of Chemistry and Biotechnology, Tallinn University of Technology, Akadeemia tee 15, 12618, Tallinn, Estonia.

Kristian Leite (K)

Department of Chemistry and Biotechnology, Tallinn University of Technology, Akadeemia tee 15, 12618, Tallinn, Estonia.
Department of Neurology, University Medicine Göttingen, Waldweg 33, 37073, Göttingen, Germany.

Jürgen Tuvikene (J)

Department of Chemistry and Biotechnology, Tallinn University of Technology, Akadeemia tee 15, 12618, Tallinn, Estonia.
Protobios LLC, 12618, Tallinn, Estonia.

Kaja Nurm (K)

Department of Chemistry and Biotechnology, Tallinn University of Technology, Akadeemia tee 15, 12618, Tallinn, Estonia.

Mari Sepp (M)

Department of Chemistry and Biotechnology, Tallinn University of Technology, Akadeemia tee 15, 12618, Tallinn, Estonia.
Center for Molecular Biology of Heidelberg University (ZMBH), 69120, Heidelberg, Germany.

Tõnis Timmusk (T)

Department of Chemistry and Biotechnology, Tallinn University of Technology, Akadeemia tee 15, 12618, Tallinn, Estonia. tonis.timmusk@taltech.ee.
Protobios LLC, 12618, Tallinn, Estonia. tonis.timmusk@taltech.ee.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH